Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Transfusion Medicine (Oxford, England)|October 25, 2021
Transfusion 2024: A 5-year plan for clinical and laboratory transfusion in EnglandShubha Allard, Jon Cort, Catherine Howell, et al.
Plos One|August 17, 2022
Cost-effectiveness of alternative minimum recall intervals between whole blood donationsZia Sadique, Sarah Willis, Kaat De Corte, et al.
Microbiology Spectrum|February 20, 2026
Bioinformatic identification of lentivirus transfer plasmid contamination causing false-positive HIV NAT results in a high-throughput molecular screening laboratoryShannah Secret, Richard Mayne, Kaitlin Reid, et al.
Transfusion|February 16, 2023
Impact of a post-donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling studyLois G Kim, Thomas Bolton, Michael J Sweeting, et al.
Vox Sanguinis|March 7, 2023
Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variant Creutzfeldt-Jakob diseaseStephen Thomas, Barnaby Roberts, Dragoslav Domanović, et al.
Trials|September 21, 2016
Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervalsCarmel Moore, Thomas Bolton, Matthew Walker, et al.
The Lancet. Haematology|January 19, 2026
Preventive interventions for vasovagal reactions in whole blood donors: a cluster-randomised, stepped-wedge, crossover trial of 73 sites involving 1·4 million donors in EnglandStephen Kaptoge, Amy McMahon, Yaning Wu, et al.
Trials|October 16, 2015
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trialClaire M Rice, David I Marks, Yoav Ben-Shlomo, et al.
Transfusion Medicine (Oxford, England)|December 20, 2020
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy studySteven Bell, Michael Sweeting, Anna Ramond, et al.
Transfusion Medicine (Oxford, England)|December 17, 2020
Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levelsHeli Harvala, Matthew L Robb, Nick Watkins, et al.
Pageof 2